产品名称Enoxolone
简述Inhibitors
纯化99.05%
生物活性Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
基因/蛋白名称Dehydrogenase inhibitor
CAS号471-53-4
计算分子量470.68
配方C30H46O4
保存3 years -20˚C powder;2 years -80˚C in solvent;
The lead time is currently 7-30 days.
